9th Circ.'s Opioid Ruling Packs Limited Punch

The Ninth Circuit's finding that McKesson's insurers need not defend the pharmaceutical company against suits from municipalities claiming its deliberate conduct increased their opioid epidemic response costs is a sting to policyholders —...

Already a subscriber? Click here to view full article